Effect of sodium bicarbonate as a pharmaceutical formulation excipient on the interaction of fluvastatin with membrane phospholipids.
Excipients in the pharmaceutical formulation of oral drugs are notably employed to improve drug stability. However, they can affect drug absorption and bioavailability. Passive transport through intestinal cell walls is the main absorption mechanism of drugs and, thus, involves an interaction with the membrane lipids. Therefore in this work, the effect of the excipient NaHCO(3) on the interaction of the anticholesterolemic drug fluvastatin sodium (FS) with membrane phospholipids was investigated by (1)H NMR and FTIR spectroscopy. Sodium bicarbonate is often combined with fluvastatin for oral delivery to prevent its degradation. We have used model DMPC/DMPS membranes to mimic the phospholipid content of gut cell membranes. The results presented in this work show a 100% affinity of FS for the membrane phospholipids that is not modified by the presence of the excipient. However, NaHCO(3) is shown to change the interaction mechanism of the drug. According to our data, FS enters the DMPC/DMPS bilayer interface by interacting with the lipids' polar headgroups and burying its aromatic moieties into the apolar core. Moreover, lipid segregation takes place between the anionic and zwitterionic lipids in the membranes due to a preferential interaction of FS with phosphatidylserines. The excipient counteracts this favored interaction without affecting the drug affinity and location in the bilayer. This work illustrates that preferential interactions with lipids can be involved in passive drug permeation mechanisms and gives evidence of a possible nonpassive role of certain excipients in the interaction of drugs with membrane lipids.
Larocque
Germain
G
Department of Chemistry, Pharmaqam/NanoQAM, Université du Québec à Montréal, P.O. Box 8888, Downtown Station, Montreal, QC, H3C 3P8, Canada.
Arnold
Alexandre A
AA
Chartrand
Etienne
E
Mouget
Yves
Y
Marcotte
Isabelle
I
D000924:Anticholesteremic Agents / Q000737:chemistry / Q000378:metabolism; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism; D002626:Chemistry, Pharmaceutical; D004134:Dimyristoylphosphatidylcholine / Q000737:chemistry / Q000378:metabolism; D005079:Excipients / Q000737:chemistry*; D005229:Fatty Acids, Monounsaturated / Q000737:chemistry / Q000378:metabolism*; D000077340:Fluvastatin; D007211:Indoles / Q000737:chemistry / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism*; D017693:Sodium Bicarbonate / Q000737:chemistry / Q000494:pharmacology*; D017550:Spectroscopy, Fourier Transform Infrared; D014494:Unithiol / Q000737:chemistry / Q000378:metabolism
D000924:Anticholesteremic Agents; D005079:Excipients; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D010743:Phospholipids; D014494:Unithiol; D000077340:Fluvastatin; D017693:Sodium Bicarbonate; D004134:Dimyristoylphosphatidylcholine
Chem Phys Lipids. 1991 Mar;57(2-3):213-26
2054905
Biochim Biophys Acta. 1984 Dec 4;779(4):381-401
6391546
Biophys J. 2004 Mar;86(3):1574-86
14990484
Pharm Acta Helv. 1996 Nov;71(5):309-27
8973162
Biochemistry. 1987 Jul 14;26(14):4408-16
3663596
Biochemistry. 1992 Sep 22;31(37):8898-905
1390677
Biochemistry. 1990 Jul 31;29(30):7077-89
2223761
Pharm Sci Technol Today. 2000 Oct 1;3(10):336-345
11050458
Biochemistry. 1984 Mar 27;23(7):1498-504
6722103
Chem Phys Lipids. 2004 Feb;127(2):175-87
14726000
J Am Chem Soc. 2001 Dec 12;123(49):12343-52
11734036
Biophys J. 1998 Apr;74(4):1871-88
9545049
Biochemistry. 1996 Jan 9;35(1):229-35
8555179
Biophys J. 1994 Dec;67(6):2367-75
7696476
Biochim Biophys Acta. 2008 Nov;1778(11):2535-43
18809375
Biochemistry. 1990 Feb 27;29(8):2008-15
2328235
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
18216768
Prog Cardiovasc Dis. 2004 Sep-Oct;47(2):73-104
15586350
Biochemistry. 1980 Jun 10;19(12):2763-9
6249340
Biochemistry. 1988 Oct 18;27(21):8239-49
3233207
Biophys J. 2000 Oct;79(4):2043-55
11023908
Biochemistry. 1987 Dec 29;26(26):8513-6
3442673
Biophys J. 2005 Mar;88(3):1887-901
15626702
Biophys J. 2003 Jul;85(1):328-39
12829487
Biochim Biophys Acta. 2010 Sep;1798(9):1651-62
20510171
Clin Pharmacol Ther. 1996 Nov;60(5):493-503
8941022
Arch Biochem Biophys. 1993 Mar;301(2):330-5
8460943
Eur J Pharm Sci. 2006 Nov;29(3-4):259-68
16781125
Biophys J. 1994 Mar;66(3 Pt 1):741-52
8011906
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jun 1;868(1-2):20-7
18479982
Biophys J. 2004 Mar;86(3):1587-600
14990485
Curr Drug Deliv. 2009 Jan;6(1):101-12
19418962
Biochemistry. 1988 Oct 18;27(21):7991-3
2906803
Biophys J. 2000 Jan;78(1):281-9
10620292
Biophys J. 2002 Apr;82(4):1818-27
11916841